NCBiotech grant goes to consortium led by Ginsburg, to explore state's leadership in personalized medicine

By ajz6@dhe.duke.edu
The North Carolina Biotechnology Center has awarded a $100,000 grant to explore the state’s readiness for a Center of Innovation (COI) to help capitalize on the growing field of personalized medicine. The grant goes to a statewide consortium of business and academic institutions, represented by Geoff Ginsburg, MD, PhD, professor of medicine (Cardiology) and executive director of the Duke Center for Personalized Medicine. The grant will help the group develop a business plan for an independent COI to accelerate the state’s efforts to commercialize personalized medicine. If that plan is subsequently approved, it will trigger a four-year, $2.5 million Phase II grant to launch the future COI. Read the full news release.

Share